echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Circulation: Features of myocarditis after COVID-19 mRNA vaccination

    Circulation: Features of myocarditis after COVID-19 mRNA vaccination

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Myocarditis has been considered a rare complication after COVID-19 mRNA vaccination, especially in young adults and adolescent men
    .

    COVID-19

    Recently, the heart blood vessels published a research article in the authoritative magazine on the field of Circulation, according to the US Centers for Disease Control (CDC) in 12-39 year-olds, per one million vaccinated mRNA vaccine, myocarditis / pericarditis incidence About 12.
    6 cases
    .

    Heart blood vessels

    In the reported cases, patients with myocarditis presented with chest pain, usually within 2-3 days after the second dose of mRNA vaccination, and accompanied by elevated cardiac troponin levels
    .


    Most electrocardiogram abnormalities with ST-segment elevation, cardiac MRI of all tested patients revealed myocarditis, and there was no evidence of acute COVID-19 or other viral infections


    Infect

    In the study, a patient with cardiomyopathy genotype was negative, but the level of autoantibodies against certain autoantigens increased, and the number of natural killer cells increased
    .


    Although the mechanism of myocarditis is not yet clear, it is speculated that the molecular simulation between the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and autoantigens triggers the previously existing and dysregulated diseases in some patients.


    Immune diagnosis

    The research data shows that although there are few cases of myocarditis, the benefits of COVID-19 mRNA vaccination-risk assessment tends to be favorable for all age groups and gender groups; therefore, it is recommended that people 12 years and older are vaccinated with COVID-19 Vaccine
    .

    Although there are few cases of myocarditis, the benefits of COVID-19 mRNA vaccination-risk assessment tends to be favorable for all age groups and gender groups; therefore, it is recommended that people 12 years and older are vaccinated against COVID-19
    .


    Original source:

    Original source:

    Biykem Bozkurt,et al.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.